APA (7th ed.) Citation

Zukin, M., Gondim, V., Shimada, A. K., Lima, E. M. e. A., Mathias, C., Barra, W. F., . . . Gelatti, A. C. Z. Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120). Sociedade Brasileira de Pneumologia e Tisiologia.

Chicago Style (17th ed.) Citation

Zukin, Mauro, et al. Durvalumab as Consolidation Therapy in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real-world Data from an Expanded Access Program in Brazil (LACOG 0120). Sociedade Brasileira de Pneumologia e Tisiologia.

MLA (9th ed.) Citation

Zukin, Mauro, et al. Durvalumab as Consolidation Therapy in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real-world Data from an Expanded Access Program in Brazil (LACOG 0120). Sociedade Brasileira de Pneumologia e Tisiologia.